KUPPUSAMY KARTHIK
SVP, Clinical Solutions
KUPPUSAMY KARTHIK has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 8, 2026.
On the most recent filing, KUPPUSAMY KARTHIK is listed as SVP, Clinical Solutions at QUEST DIAGNOSTICS INC. Inside the rolling window, KUPPUSAMY KARTHIK reported no open-market purchases and 2 open-market sales totaling $2.2M in DGX. The largest disclosed transaction in the window is a sale of 8,147 DGX shares on Jun 4, 2026, worth $1.6M.
Companies traded
Other insiders at DGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KUPPUSAMY KARTHIK made?
KUPPUSAMY KARTHIK has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does KUPPUSAMY KARTHIK trade?
KUPPUSAMY KARTHIK has filed SEC Form 4 disclosures for 1 company, including DGX.
When was KUPPUSAMY KARTHIK's most recent SEC Form 4 filing?
KUPPUSAMY KARTHIK's most recent SEC Form 4 filing on Tracefour is dated Jun 8, 2026.
What is KUPPUSAMY KARTHIK's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, KUPPUSAMY KARTHIK is listed as SVP, Clinical Solutions.
What is KUPPUSAMY KARTHIK's total buy and sell value in the current window?
Inside the rolling retention window, KUPPUSAMY KARTHIK bought $0 and sold $2.2M based on SEC Form 4 filings.
What was KUPPUSAMY KARTHIK's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,147 DGX shares on 2026-06-04, worth $1.6M, per SEC Form 4 filings.